BB BIOTECH AG

BB Biotech AG publishes its interim report

BB Biotech presents solid first-quarter results; biotech stock market impacted by shifting views on interest rates

BB BIOTECH AG: Dr. Thomas von Planta, buy

BB BIOTECH AG: Dr. Thomas von Planta, buy

Shareholders at BB Biotech AG’s AGM vote in favor of all proposals and approve the dividend of CHF 2.00 per share

BB BIOTECH AG: Prof. Dr. Mads Krogsgaard Thomsen, buy